Option Care Health (NASDAQ:OPCH) Cut to Equal Weight at Stephens

Stephens downgraded shares of Option Care Health (NASDAQ:OPCH) from an overweight rating to an equal weight rating in a report published on Friday morning, MarketBeat reports. Stephens currently has $24.00 target price on the stock.

A number of other research firms have also recently commented on OPCH. UBS Group reiterated a “buy” rating on shares of Option Care Health in a report on Tuesday, June 16th. JPMorgan Chase & Co. decreased their price objective on shares of Option Care Health from $40.00 to $33.00 and set an “overweight” rating for the company in a report on Monday, May 4th. The Goldman Sachs Group began coverage on Option Care Health in a research report on Monday, June 8th. They issued a “neutral” rating and a $22.00 price objective on the stock. TD Cowen cut their target price on Option Care Health from $37.00 to $23.00 and set a “hold” rating on the stock in a research note on Friday, May 1st. Finally, Weiss Ratings lowered Option Care Health from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. Eight analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat, Option Care Health has a consensus rating of “Moderate Buy” and an average price target of $30.08.

Option Care Health Stock Performance

Shares of Option Care Health stock opened at $21.74 on Friday. The stock has a market cap of $3.41 billion, a price-to-earnings ratio of 16.85, a PEG ratio of 1.21 and a beta of 0.65. The firm’s 50-day moving average is $21.15 and its 200 day moving average is $27.46. Option Care Health has a 1 year low of $18.01 and a 1 year high of $36.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 1.07.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings data on Thursday, April 30th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.37 by $0.03. The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.39 billion. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. Option Care Health’s revenue for the quarter was up 1.3% on a year-over-year basis. During the same period in the prior year, the firm posted $0.40 EPS. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Sell-side analysts anticipate that Option Care Health will post 1.64 EPS for the current fiscal year.

Insider Activity

In related news, CEO John Charles Rademacher bought 12,500 shares of the company’s stock in a transaction that occurred on Monday, May 4th. The shares were bought at an average price of $21.18 per share, for a total transaction of $264,750.00. Following the completion of the acquisition, the chief executive officer owned 695,152 shares of the company’s stock, valued at $14,723,319.36. This trade represents a 1.83% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Timothy P. Sullivan bought 24,154 shares of the business’s stock in a transaction on Thursday, May 7th. The stock was bought at an average cost of $20.69 per share, with a total value of $499,746.26. Following the transaction, the director owned 73,383 shares in the company, valued at $1,518,294.27. This trade represents a 49.06% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders purchased 73,264 shares of company stock valued at $1,548,316 over the last three months. Insiders own 1.70% of the company’s stock.

Hedge Funds Weigh In On Option Care Health

Hedge funds and other institutional investors have recently modified their holdings of the company. V Square Quantitative Management LLC bought a new stake in shares of Option Care Health in the fourth quarter worth $25,000. Advisory Services Network LLC bought a new position in Option Care Health in the third quarter valued at about $35,000. McIlrath & Eck LLC bought a new position in Option Care Health in the second quarter valued at about $37,000. Caitong International Asset Management Co. Ltd purchased a new position in Option Care Health in the third quarter worth about $38,000. Finally, Quarry LP grew its stake in shares of Option Care Health by 502.7% during the 3rd quarter. Quarry LP now owns 1,549 shares of the company’s stock valued at $43,000 after purchasing an additional 1,292 shares during the period. 98.05% of the stock is owned by institutional investors.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.